Mutamycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 69448-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mutamycin (NDC 69448-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Biopharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg Carton Label (Mitomycin Carton 20mg)

20mg Carton Label (Mitomycin Carton 20mg)
Label for MUTAMYCIN 20 mg for Injection USP by Accord BioPharma Inc. This label indicates the product contains mitomycin as the active ingredient at 20 mg strength. It includes Rx only status, warnings to administer intravenously to avoid tissue damage, manufacturer information from Accord BioPharma Inc. and Intas Pharmaceuticals Limited, and storage instructions for the dry powder and reconstituted solution. The label includes barcode and NDC 69448-002-11.*
FDA Label Image

40mg Carton Label (Mitomycin Carton 40mg)

40mg Carton Label (Mitomycin Carton 40mg)
Packaging label for MUTAMYCIN 40 mg for Injection USP (Mitomycin) by Accord BioPharma Inc. The label includes NDC 69448-003-38 and indicates the drug is Rx Only. It warns that the drug must be administered intravenously to avoid tissue damage. The label states it is manufactured by Intas Pharmaceuticals Limited in India and distributed by Accord BioPharma in Durham, NC. Storage and handling instructions are provided, along with a barcode and instructions for lot number and expiration date on the top flap.*
FDA Label Image

5mg Carton Label (Mitomycin Carton 5mg)

5mg Carton Label (Mitomycin Carton 5mg)
Packaging label for MUTAMYCIN (Mitomycin) For Injection USP, 5 mg strength, by Accord BioPharma Inc. The label includes dosage form as injection, NDC 69448-001-05, and warnings to administer intravenously to avoid tissue damage. It shows manufacturing details by Intas Pharmaceuticals Limited, India. Instructions for reconstitution, storage conditions, and usual dosage reference are also included.*
FDA Label Image

Structural Formula (Mitomycin Str)

Structural Formula (Mitomycin Str)
Chemical structure diagram of the active ingredient in MUTAMYCIN, showing molecular groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.